KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer is a research paper published in Cancer Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA054174
NCI NIH HHS
Grant: K23 CA178204
Bladder Cancer Advocacy Network
Max and Minnie Tomerlin Voelcker Fund
National Cancer Institute
FWCI
0.90
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals